Screener
Chemed CHE Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Chemed’s 8-K, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:30 PM EDT
- Accession
- 0000019584-26-000018
FAQ
- What is Chemed's cash & equivalents?
- Chemed (CHE) reported cash & equivalents of $40.22M in Q2 2026.
- How has Chemed's cash & equivalents changed year-over-year?
- Chemed's cash & equivalents decreased by 83.9% year-over-year, from $249.9M to $40.22M.
- What is the long-term trend for Chemed's cash & equivalents?
- Over 5 years (2020 to 2025), Chemed's cash & equivalents has grown at a -14.5% compound annual growth rate (CAGR), from $162.68M to $74.52M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Chemed's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude